Displaying One Session

WSAVA-Mandated or Sponsored Session
Moderators
Room
Hall 711
Date
07/17/19, Wednesday
Time
10:45 AM - 11:35 AM
Presentation Type
Level 2: Requires general knowledge of the literature and professional practice within the areas covered
Session Description
Session Sponsored by WSAVA One Health Committee
WSAVA-Mandated or Sponsored Session

Towards a future Path in Comparative Oncology: Synthesis of WSAVA One Health Committee Precongress Gap Analysis

Lecture Time
10:45 AM - 11:35 AM
Room
Hall 711
Date
07/17/19, Wednesday
Time
10:45 AM - 11:35 AM

Abstract

Abstract Body

Towards a future Path in Comparative Oncology: of WSAVA One Health Committee Pre-congress Gap Analysis-


Based on the promise and the State of the field there is an urgency and opportunity to accelerate the integration of this Comparative Approach to Cancer drug development. A forward and future facing strategy is necessary. The WSAVA One Health Committee has organized a Comparative Oncology 2020Precogress, meeting that seeks to develop an agenda towards this strategy through an animal-health centric gap analysis. As part of this gap analysis, we propose encouragement of a new approach that seeks to bring interested human and animal health pharma/biotech entities together. Named Drug DISCO: Development Incentivization Strategy in Comparative Oncology, this distinct perspective will include the following:
Building connections between human and animal health drug development efforts;
Positioning Comparative Oncology as a parallel rather than preclinical model strategy;


We seek to determine if/how this part of a strategy can be integrated within the broader gap analysis and likely include venues, processes and strategies needed to build awareness of Drug DISCO.

As a result, synergies will be created to leverage resources, de-risk drug development, and generate returns simultaneously within a human and animal health drug development paths.



Collapse